This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Health Care Stocks Rising on Major Volume

Bio-Reference Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Bio-Reference Laboratories (BRLI) is engaged in providing laboratory testing services to customers in the greater New York metropolitan area, as well as to customers in other states. This stock is trading up 3.3% at $30.80 in recent trading.

Today's Volume: 281,000

Average Volume: 234,122

Volume % Change: 160%

From a technical perspective, BRLI is moving notably higher here with above-average volume. This move has started to push BRLI into breakout territory, since it's taken out some past overhead resistance at $30.15. At last check, BRLI has hit an intraday high of $31 and volume is well above its three-month average action of 234,122 shares.

Traders should now look for long-biased trades in BRLI as long as it's trending above today's low of $29.84, and then once it sustains a move or close above $30.15 with volume that's near or above 234,122 shares. If we continue to see BRLI maintain that trend, then this stock has an excellent chance to tag $35 to $40 in the near future.

Keep in mind that BRLI is now trading in new 52-week-high territory, which is bullish technical price action.

To see more stocks rising on unusual volume, check out the Stocks Rising On Unusual Volume portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to and maintains the website, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.
5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALR $39.25 -9.80%
ESC $33.46 -0.39%
NVDQ $11.52 -1.40%
BRLI $34.61 -0.97%
AAPL $93.31 -1.60%


Chart of I:DJI
DOW 17,740.91 -89.85 -0.50%
S&P 500 2,062.19 -13.62 -0.66%
NASDAQ 4,774.2780 -31.0130 -0.65%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs